newsfilter
← Latest News
GlobeNewswire·

Opiant Pharmaceuticals to Participate in 32nd Oppenheimer Healthcare Conference

SANTA MONICA, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that its Chief Executive Officer,